NanoViricides Inc. (NNVC)

[Nanotoday]

In these studies, several nanoviricide drug candidates were shown to have equal effectiveness in terms of multiple parameters to a clinical anti-HIV HAART three-drug cocktail. The HAART cocktail drugs were administered at a much greater total dosage (4,100 mg/kg of HAART) than the nanoviricides (only 150mg/kg of the nanoviricides). This study evaluated several parameters including the reduction of HIV viral load, improvement in CD4+/CD8+ double-positive human T cells, and HIV particle count inside human T cells in the transplant, among others. The best nanoviricide drug candidate was greater than 25X (2,500%) superior to the HAART drug cocktail based on the amount of drug that produced comparable or superior effect.

Does this mean that the only benefit of HIV-Cide vs. HAART is the reduced dosage. That they both achieve the same results, but you need a lot less HIV-Cide? that the superior effectiveness was based on the amount needed to achieve the same effect?